Selonsertib,
1448428-04-3,
GS-4997,
UNII-NS3988A2TC,
Selonsertib(GS-4997),
Selonsertib (GS-4997),
NS3988A2TC,
5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide,
5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl]benzamide,
GS-4997; GS4997; GS 4997; Selonsertib free base ;5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide,
Selonsertib [INN],
GS 4997,
selonsertib-gs-4997,
GS-4997; Selonsertib,
Selonsertib (USAN/INN),
Selonsertib [USAN:INN],
GTPL9040,
CHEMBL3916717,
SCHEMBL14672984,
KS-00000LEZ,
YIDDLAAKOYYGJG-UHFFFAOYSA-N,
BCP17814,
EX-A1150,
EX-A1618,
BDBM50212258,
GS4997,
MFCD29920355,
s8292,
AKOS027338646,
Selonsertib pound GS-4997 pound(c),
ZINC149387856,
ACN-041439,
CS-5328,
SB17466,
NCGC00479176-02,
AK340936,
AS-35035,
GS-4997),
HY-18938,
Selonsertib HCl salt, GS-4997 HCl salt,
D10988,
5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-{6-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]pyridin-2-yl}benzamid,
5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-{6-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]pyridin-2-yl}benzamide,
A15991,
1448428-05-4,